1. Ki-moon B Message on International Day Against Drug Trafficking and Abuse. http://www.unis.unvienna.org/unis/en/pressrels/2015/unissgsm645.html Date: 26 June 2015 View in Article Google Scholar

2. UN General Assembly Transforming our world: the 2030 agenda for sustainable development. United Nations , New York View in Article Google Scholar

3. West Africa Commission on Drugs Not just in transit: drugs, the state and society in West Africa. West Africa Commission on Drugs , Accra View in Article Google Scholar

4. UN High Commissioner for Human Rights Study on the impact of the world drug problem on the enjoyment of human rights. Human Rights Council, 30th session. Office of the UN High Commissioner for Human Rights , Geneva View in Article Google Scholar

5. UN General Assembly Political declaration of the UN General Assembly Special Session on the world drug problem. United Nations , New York View in Article Google Scholar

6. UN United Nations Single Convention on Narcotic Drugs. 1961 as amended by the 1972 protocol amending the Single Convention on Narcotic Drugs. United Nations , New York View in Article Google Scholar

7. UN Office on Drugs and Crime World Drug Report. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

8. McAllister WB Reflections on a century of international drug control. in: Collins J Governing the global drug wars. London School of Economics , London : 10-16 View in Article Google Scholar

9. Collins J The economics of new global strategy. in: Collins J Ending the drug wars: Report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics , : 8-15 View in Article Google Scholar

10. UN International Drug Control Programme Key statistics: illicit drug production, trafficking and consumption. Information sheet no. 2 for UN General Assembly Special Session on the World Drug Problem. United Nations International Drug Control Programme , Vienna View in Article Google Scholar

11. UN Office on Drugs and Crime World drug report. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

12. UN Commission on Narcotic Drugs Joint ministerial statement of the 2014 high-level review by the Commission on Narcotic Drugs of the implementation by member states of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem. United Nations , Vienna View in Article Google Scholar

13. UNDP Addressing the development dimensions of drug policy. United Nations Development Programme , New York View in Article Google Scholar

14. WHO Executive Board Public health dimension of the world drug problem including in the context of the Special Session of the UN General Assembly on the World Drug Problem, to be held in 2016: report of the secretariat. 138th session, doc. EB 138/11, 2016. World Health Organization , Geneva View in Article Google Scholar

15. Organization of American States The drug problem in the Americas. Organization of American States , Washington, DC View in Article Google Scholar

16. Global Commission on Drug Policy War on drugs. Global Commission on Drug Policy , Rio de Janeiro View in Article Google Scholar

17. Latin American Commission on Drugs and Democracy Drugs and democracy: toward a paradigm shift. Latin American Commission on Drugs and Democracy , Rio de Janeiro View in Article Google Scholar

18. Global Commission on HIV and the Law HIV and the law: risks, rights, and health. United Nations Development Programme , New York View in Article Google Scholar

19. UN Office on Drugs and Crime Regional Centre for East Asia and the Pacific Drug-free ASEAN 2015: status and recommendations. United Nations Office on Drugs and Crime , Bangkok View in Article Google Scholar

21. US Centers for Disease Control and Prevention CDC vital aigns: today's heroin epidemic. http://www.cdc.gov/vitalsigns/heroin/ View in Article Google Scholar

22. King NB

Fraser V

Boikos C

Richardson R

Harper S Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: a systematic review. Am J Public Health. 104 : e32-e42 View in Article PubMed

Crossref

Google Scholar

23. Canadian HIV/AIDS Legal Network CDPC Drug policy and overdose prevention and response. http://drugpolicy.ca/wp-content/uploads/2015/09/CDPC-Overdose-Brief-Final-Web.pdf View in Article Google Scholar

24. Zezima K Presidential candidates are actually talking about America's heroin issue. https://www.washingtonpost.com/politics/drug-epidemic-shapes-messages-on-the-presidential-campaign-trail/2015/06/03/2f63761c-00d0-11e5-805c-c3f407e5a9e9_story.html View in Article Google Scholar

25. Case A

Deaton A Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci USA. 112 : 15078-15083 View in Article Scopus (116)

PubMed

Crossref

Google Scholar

26. Seelye KQ In heroin crisis, white families seek gentler war on drugs. http://www.nytimes.com/2015/10/31/us/heroin-war-on-drugs-parents.html?_r=0 View in Article Google Scholar

28. Ingold J Marijuana case filings plummet in Colorado following legalization. Denver Post. http://www.denverpost.com/marijuana/ci_24894248/marijuana-case-filings-plummet-colorado-following-legalization View in Article Google Scholar

29. WHO World report on violence and health. World Health Organization , Geneva View in Article Google Scholar

30. WHO

UN Office on Drugs and Crime

UNDP Global status report on violence prevention 2014. World Health Organization , Geneva View in Article Google Scholar

32. Osorio J The contagion of drug violence: spatiotemporal dynamics of the Mexican war on drugs. J Conflict Resolution. 59 : 1403-1432 View in Article Scopus (0)

Crossref

Google Scholar

33. UN Office on Drugs and Crime World crime trends and emerging issues and responses in the field of crime prevention and criminal justice. 23rd session, Commission on Crime Prevention and Criminal Justice. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

34. UN Office on Drugs and Crime (UNODC) Transnational organized crime in Central America and the Caribbean: a threat assessment. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

35. Center for Gender and Refugee Studies A treacherous journey: child migrants navigating the US immigration system. Hastings College of Law , San Francisco View in Article Google Scholar

36. Mares A The Rise of femicide and women in drug trafficking. Council on Hemispheric Affairs , Washington, DC View in Article Google Scholar

37. Fox E How the drug trade fuels femicide in Central America. http://www.insightcrime.org/news-analysis/how-the-drug-trade-fuels-femicide-in-central-america View in Article Google Scholar

38. Cantor DJ The new wave: forced displacement caused by organized crime in Central America and Mexico. Refugee Surv Q. 33 : 34-68 View in Article Scopus (0)

Crossref

Google Scholar

39. Atuesta Becerra L Addressing the costs of prohibition: internally displaced populations in Colombia and Mexico. in: Collins J Ending the drug wars: report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics , London : 49-54 View in Article Google Scholar

40. Canudas-Romo V

García-Guerrero VM

Echarri-Cánovas CJ The stagnation of the Mexican male life expectancy in the first decade of the 21st century: the impact of homicides and diabetes mellitus. J Epidemiol Comm Health. 69 : 28-34 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

41. Gonzalez-Perez GJ

Vega-Lopez MG

Cabrera-Pivaral CE Impact of homicide on male life expectancy in Mexico. Pan Am J Public Health. 32 : 335-342 View in Article Scopus (0)

Crossref

Google Scholar

42. Mexican National Institute of Statistics and Geography Administrative registers of death. http://www.inegi.org.mx/est/contenidos/proyectos/registros/vitales/mortalidad/default.aspx View in Article Google Scholar

43. Kim HJ

Fay MP

Feuer EJ

Midthune DN Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 19 : 335-351 View in Article Scopus (1431)

PubMed

Crossref

Google Scholar

44. Heinle K

Molzahn C

Shirk DA Drug violence in Mexico: data analysis through 2014. University of San Diego Justice in Mexico Project , San Diego View in Article Google Scholar

45. Espinosa V

Rubin DB Did the military interventions in the Mexican drug war increase violence?. Am Statistician. 69 : 17-27 View in Article Scopus (0)

Crossref

Google Scholar

46. Perez Correa C

Azeola E Resultados de la primera encuesta realizada en los Centros Federales de Readaptación Social. CIDE , Mexico City View in Article Google Scholar

47. Madrazo Lajous A The constitutional costs of the ‘war on drugs’. in: Collins J Ending the war on drugs: report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics , London : 55-60 View in Article Google Scholar

48. Mejia D

Restrepo P Why is strict prohibition collapsing?. in: Collins J Ending the war on drugs: report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics , London : 26-32 View in Article Google Scholar

50. Grillo I Legalization of marijuana has hit Mexican cartels' cross-border trade. http://time.com/3801889/us-legalization-marijuana-trade/ View in Article Google Scholar

51. Mejia D

Restrepo P Bushes and bullets: illegal cocaine markets and violence in Colombia. Documento CEDE #53. Universidad de los Andes , Bogotá View in Article Google Scholar

52. UN General Assembly Resolution adopted by the General Assembly on 20 December 2012: international cooperation against the world drug problem. UN doc. A/RES/67/193, 23 April 2013; 2012. United Nations , New York View in Article Google Scholar

55. UNAIDS The gap report. UNAIDS , Geneva View in Article Google Scholar

56. UNAIDS How AIDS changed everything. UNAIDS , Geneva View in Article Google Scholar

57. WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection. World Health Organization , Geneva View in Article Google Scholar

58. Hagan H

Pouget ER

Des Jarlais DC

Lelutiu-Weinberger C Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol. 168 : 1099-1109 View in Article Scopus (98)

PubMed

Crossref

Google Scholar

60. WHO

UN Office on Drugs and Crime

UN Joint Programme on HIV/AIDS Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users—2012 revision. World Health Organization , Geneva View in Article Google Scholar

61. Wodak A

Cooney A Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. World Health Organization , Geneva View in Article Google Scholar

62. Aspinall EJ

Nambiar D

Goldberg DJ

et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 43 : 235-248 View in Article Scopus (37)

PubMed

Crossref

Google Scholar

64. Turner KM

Hutchinson S

Vickerman P

et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 106 : 1978-1988 View in Article Scopus (134)

PubMed

Crossref

Google Scholar

65. MacArthur GJ

Minozzi S

Martin N

et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 345 : e5945 View in Article Scopus (117)

PubMed

Crossref

Google Scholar

66. Tsui JI

Evans JL

Lum PJ

Hahn JA

Page K Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 174 : 1974-1981 View in Article Scopus (35)

PubMed

Crossref

Google Scholar

67. Nolan S

Lima VD

Fairbairn N

et al. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction. 109 : 2053-2059 View in Article Scopus (30)

PubMed

Crossref

Google Scholar

68. White B

Dore GJ

Lloyd AR

Rawlinson WD

Maher L Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study. Med J Aust. 201 : 326-329 View in Article Scopus (30)

PubMed

Crossref

Google Scholar

69. Palmateer NE

Taylor A

Goldberg DJ

et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 9 : e104515 View in Article Scopus (16)

PubMed

Crossref

Google Scholar

70. Van Den Berg C

Smit C

Van Brussel G

Coutinho R

Prins M Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 102 : 1454-1462 View in Article Scopus (189)

PubMed

Crossref

Google Scholar

71. Vickerman P

Martin N

Turner K

Hickman M Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction. 107 : 1984-1995 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

72. Guise A

Kazatchkine M

Rhodes T

Strathdee SA Successful methadone delivery in east Africa and its global implications. Clin Infect Dis. 59 : 743-744 View in Article PubMed

Crossref

Google Scholar

73. European Monitoring Centre on Drugs and Drug Addiction European drug report 2015: trends and development. European Monitoring Centre on Drugs and Drug Addiction , Lisbon View in Article Google Scholar

74. Harm Reduction International Global state of harm reduction. Harm Reduction International , London View in Article Google Scholar

76. Hoang TV

Ha TT

Hoang TM

et al. Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response. Harm Reduct J. 12 : 39 View in Article PubMed

Crossref

Google Scholar

82. Reddon H

Milloy MJ

Simo A

Montaner J

Wood E

Kerr T Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav. 18 : 740-746 View in Article Scopus (17)

PubMed

Crossref

Google Scholar

83. Bach P

Wood E

Dong H

et al. Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study. BMC Infect Dis. 15 : 537 View in Article PubMed

Crossref

Google Scholar

84. Lappalainen L

Nolan S

Dobrer S

et al. Dose–response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids. Addiction. 110 : 1330-1339 View in Article PubMed

Crossref

Google Scholar

88. Momenghalibaf A Hepatitis C treatment: price, profits, and barriers to access. Open Society Foundations , New York View in Article Google Scholar

89. Ford N

Singh K

Cooke GS

et al. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis. 54 : 1465-1472 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

92. Aspinall EJ

Corson S

Doyle JS

et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis. 57 : S80-S89 View in Article Scopus (107)

PubMed

Crossref

Google Scholar

93. Martin NK

Vickerman P

Grebely J

et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 58 : 1598-1609 View in Article Scopus (147)

PubMed

Crossref

Google Scholar

94. Martin NK

Vickerman P

Miners A

et al. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology. 55 : 49-57 View in Article Scopus (106)

PubMed

Crossref

Google Scholar

95. Martin NK

Hickman M

Hutchinson SJ

Goldberg DJ

Vickerman P Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 57 : S39-S45 View in Article Scopus (73)

PubMed

Crossref

Google Scholar

96. WHO

UN Office on Drugs and Crime

N Population Fund

et al. HIV and young men who have sex with men: technical brief. World Health Organization , Geneva View in Article Google Scholar

97. Shoptaw S

Reback CJ Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction. 102 : 130-135 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

99. Nguyen TV

Van Khuu N

Nguyen PD

et al. Sociodemographic factors, sexual behaviors, and alcohol and recreational drug use associated with HIV among men who have sex with men in Southern Vietnam. AIDS Behav. ( ) https://doi.org/10.1007/s10461-015-1265-x View in Article Scopus (2)

Crossref

Google Scholar

100. Melendez-Torres GJ

Bourne A Illicit drug use and its association with sexual risk behaviour among MSM: more questions than answers?. Curr Opin Infect Dis. 29 : 58-63 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

103. Coffin PO

Rowe C

Santos GM Novel interventions to prevent HIV and HCV among persons who inject drugs. Curr HIV/AIDS Rep. 12 : 145-163 View in Article PubMed

Crossref

Google Scholar

107. Panitchpakdi P The imbalance between government and civil society in Global Fund processes: a view from Thailand. Glob Fund Obs. 65 : 4-6 View in Article Google Scholar

108. Cook C

Bridge J

McLean S

Phelan M

Barrett D The funding crisis for harm reduction: donor retreat, government neglect and the way forward. Harm Reduction International/International HIV/AIDS Alliance and International Drug Policy Consortium , London View in Article Google Scholar

109. Eurasian Harm Reduction Network Alert announcement: Serbia is losing harm reduction!. http://www.harm-reduction.org/blog/alert-announcement-serbia-losing-harm-reduction View in Article Google Scholar

110. Harm Reduction International 10 by 20: a call to redirect resources from the war on drugs to harm reduction—10% by 2020. Harm Reduction International , London View in Article Google Scholar

111. Niculescu I

Paraschiv S

Paraskevis D

et al. Recent HIV-1 outbreak among intravenous drug users in romania: evidence for cocirculation of CRF14_BG and subtype F1 strains. AIDS Res Human Retrovir. 31 : 488-495 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

112. Botescu A

Abagiu A

Mardarescu M

Ursan M HIV/AIDS among injecting drug users in Romania: report of a recent outbreak and initial response policies. European Monitoring Centre on Drugs and Drug Addiction , Lisbon View in Article Google Scholar

113. Paraskevis D

Nikolopoulos G

Fotiou A

et al. Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLoS One. 8 : e78941 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

115. European Monitoring Centre on Drugs and Drug Addiction Harm reduction overview for Greece. http://www.emcdda.europa.eu/country-data/harm-reduction/Greece View in Article Google Scholar

117. Ungar L Funding ban on needle exchanges effectively lifted. http://www.usatoday.com/story/news/nation/2016/01/07/funding-ban-needle-exchanges-effectively-lifted/78420894/ View in Article Google Scholar

118. Conrad C

Bradley HM

Broz D

et al. Community outbreak of HIV Infection linked to injection drug use of oxymorphone—Indiana, 2015. MMWR. 64 : 443-444 View in Article PubMed

Google Scholar

119. Government of Australia National Centre in HIV Epidemiology and Clinical Research Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs in Australia. Government of Australia , Canberra View in Article Google Scholar

120. Naning H

Kerr C

Kamarulzaman A

et al. Return on investment and cost-effectiveness of harm reduction program in Malaysia. World Bank , Washington, DC View in Article Google Scholar

122. Brooner R

Kidorf M

King V

Beilenson P

Svikis D

Vlahov D Drug abuse treatment success among needle exchange participants. Public Health Rep. 113 : 129-139 View in Article PubMed

Google Scholar

123. WHO

UN Office on Drugs and Crime

UN Joint Programme on HIV/AIDS Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. World Health Organization , Geneva View in Article Google Scholar

124. Burris S Law in a social determinants strategy: a public health law research perspective. Public Health Rep. 126 : 22-27 View in Article PubMed

Crossref

Google Scholar

125. Lunze K

Raj A

Cheng DM

et al. Punitive policing and associated substance use risks among HIV-positive people in Russia who inject drugs. J Int AIDS Soc. 17 : 19043 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

126. Government of the Russian Federation HIV infection in the Russian Federation. http://www.hivrussia.ru/files/spravkaHIV2014.pdf View in Article Google Scholar

127. Canadian HIV AIDS Legal Network Legislating for health and human rights—model law on drug use and HIV/AIDS. Module 2: treatment for drug dependence. Canadian HIV/AIDS Legal Network , Toronto View in Article Google Scholar

128. Tanguay P

Ngamee V CHAMPION-IDU: innovations, best practices, lessons learned. Population Services International , Bangkok View in Article Google Scholar

129. Sarang A

Rhodes T

Sheon N Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan. 28 : 681-691 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

130. Ti L

Hayashi K

Kaplan K

Suwannawong P

Wood E

Kerr T Contextual factors associated with rushed injecting among people who inject drugs in Thailand. Prev Sci. 16 : 313-320 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

131. Ahmed T

Long TN

Huong PT

Stewart DE Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 15 : 32 View in Article PubMed

Crossref

Google Scholar

133. VOCAL-NY Users Union Beyond methadone: improving health and empowering patients in opioid treatment programs. VOCAL , New York View in Article Google Scholar

134. Open Society Foundations To protect and serve: how police, sex workers, and people who use drugs are joining forces to improve health and human rights. Open Society Foundations , New York View in Article Google Scholar

135. Wood E

Kerr T

Small W

Jones J

Schechter MT

Tyndall MW The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr. 34 : 116-117 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

136. Maher L

Dixon D Cost of crackdowns: policing Cabramatta's herion market. Curr Issues Crim Just. 13 : 5 View in Article Google Scholar

139. WHO Global tuberculosis report. World Health Organization , Geneva View in Article Google Scholar

140. WHO

UN Office on Drugs and Crime

UN Joint Programme on HIV/AIDS Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach. World Health Organization , Geneva View in Article Google Scholar

141. Getahun H

Gunneberg C

Sculier D

Verster A

Raviglione M Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin HIV AIDS. 7 : 345-353 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

143. WHO Drug-resistant tuberculosis: frequently asked questions. World Health Organization , Geneva View in Article Google Scholar

145. WHO Policy guidelines for integrating collaborative TB and HIV services within the comprehensive package of harm reduction for people who inject drugs. World Health Organization , Geneva View in Article Google Scholar

146. Keshavjee S

Sweeney C

Yedilbayev A

Taran D

Solovyova A

Gelmanova I The Sputnik Initiative: patient-centered accompaniment for tuberculosis in Russia. Partners Health Report. 1 : 4-27 View in Article Google Scholar

148. Getahun H

Baddeley A

Raviglione M Managing tuberculosis in people who use and inject illicit drugs. Bull World Health Organ. 91 : 154-156 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

149. WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. World Health Organization , Geneva View in Article Google Scholar

150. Rosmarin A

Eastwood N A quiet revolution: drug decriminalisation policies in practice across the globe. Release , London View in Article Google Scholar

151. UK Home Office International comparators. Home Office , London View in Article Google Scholar

152. DeBeck K

Kerr T

Li K

Milloy MJ

Montaner J

Wood E Incarceration and drug use patterns among a cohort of injection drug users. Addiction. 104 : 69-76 View in Article Scopus (25)

PubMed

Crossref

Google Scholar

153. Reinarman C

Cohen PD

Kaal HL The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health. 94 : 836-842 View in Article PubMed

Crossref

Google Scholar

154. Uprimny R

Esther D

Parra J Addicted to punishment: the disproportionality of drug laws in Latin America. Colectivo de Estudios de Drogas y Derecho (CEDD) , Mexico City View in Article Google Scholar

155. Penal Reform International Global prison trends 2015. Penal Reform International , London View in Article Google Scholar

156. Giacomello C How the drug trade criminalizes women disproportionately. NACLA Report Americas. 47 : 38-41 View in Article Crossref

Google Scholar

157. Organization of American States Inter-American Commission of Women Women and drugs in the Americas: a policy working paper. Inter-American Commission of Women , Washington, DC View in Article Google Scholar

158. Carson A Prisoners in 2014. Bureau of Justice Statistics , Washington, DC View in Article Google Scholar

160. Gallahue P

Gunawan R

Rahman F

El Mufti K

Din NU

Felten R The death penalty for drug offences: global overview 2012. International Harm Reduction Association , London View in Article Google Scholar

161. UN Commentary on the Single Convention on Narcotic Drugs 1961, E.73.XI.1. https://www.unodc.org/documents/treaties/organized_crime/Drug%20Convention/Commentary_on_the_single_convention_1961.pdf View in Article Google Scholar

162. Lines R

Barrett D

Gallahue P The death penalty for drug offenses: Asian values or treaty influence?. http://opiniojuris.org/2015/05/21/guest-post-the-death-penalty-for-drug-offences-asian-values-or-drug-treaty-influence/ View in Article Google Scholar

163. Grover A Report of the special rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, Human Rights UN General Assembly, 65th Session. UN doc. A/65/255. United Nations , New York View in Article Google Scholar

164. Phipps C Who were the eight people executed by Indonesia?. http://www.theguardian.com/world/2015/apr/29/bali-nine-who-are-the-nine-people-being-executed-by-indonesia View in Article Google Scholar

165. Gallahue P Drugs and the death penalty. Open Society Foundations , New York View in Article Google Scholar

166. Walmsley R World prison population list. 10th edn. International Centre for Prison Studies , Essex View in Article Google Scholar

167. Snyder HN

Mulako-Wangota J Arrests in the United States, 1980–2012. Bureau of Justice Statistics , Washington, DC View in Article Google Scholar

168. Sentencing Project Facts about prisons and people in prisons. http://sentencingproject.org/doc/publications/inc_Facts%20About%20Prisons.pdf View in Article Google Scholar

170. Carson A Prisoners in 2013. Bureau of Justice Statistics , Washington, DC View in Article Google Scholar

171. Levine HG

Siegel L Marijuana madness: the scandal of New York City's racist marijuana possession arrests. in: Eterno JA The New York City Police Department: the impact of its policies and practices. CRC Press , New York : 117-161 View in Article Google Scholar

172. Snyder HN Arrests in the United States, 1990-2010. Bureau of Justice Statistics , Washington, DC View in Article Google Scholar

173. Adimora AA

Schoenbach VJ

Martinson FE

Donaldson KH

Stancil TR

Fullilove RE Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. J Acquir Immune Defic Syndr. 34 : 423-429 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

174. Widman L

Noar SM

Golin CE

Willoughby JF

Crosby R Incarceration and unstable housing interact to predict sexual risk behaviours among African American STD clinic patients. Int J STD AIDS. 25 : 348-354 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

175. Johnson RC

Raphael S The effects of male incarceration dynamics on acquired immune deficiency syndrome infection rates among African American women and men. J Law Econ. 52 : 251-293 View in Article Scopus (67)

Crossref

Google Scholar

176. Jeffries S

Stenning P Sentencing, aboriginal offenders: law, policy, and practice in three Countries. Can J Criminol Criminal Justice. 56 : 447-494 View in Article Crossref

Google Scholar

178. Minority Rights Group International World directory of minorities and indigenous peoples: Brazil—Afro-Brazilians. Minority Rights Group International , London View in Article Google Scholar

179. Horwitz S Justice Department set to free 6000 prisoners, largest one-time release. https://www.washingtonpost.com/world/national-security/justice-department-about-to-free-6000-prisoners-largest-one-time-release/2015/10/06/961f4c9a-6ba2-11e5-aa5b-f78a98956699_story.html View in Article Google Scholar

180. UN Economic and Social Council United Nations rules for the treatment of women prisoners and non-custodial measures for women offenders (the Bangkok Rules). United Nations , New York View in Article Google Scholar

181. Iakobishvili E Cause for alarm: the incarceration of women for drug offences in Europe and central Asia, and the need for legislative and sentencing reform. International Harm Reduction Association , London View in Article Google Scholar

182. UN Office on Drugs and Crime

UN Women

WHO

International Network of People Who Use Drugs Women who inject drugs and HIV: addressing specific needs. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

183. Green KM

Ensminger ME

Robertson JA

Juon HS Impact of adult sons' incarceration on African American mothers' psychological distress. J Marriage Family. 68 : 430-441 View in Article Scopus (0)

Crossref

Google Scholar

184. Lee H

Wildeman C Things fall apart: Health consequences of mass imprisonment for African American women. Rev Black Political Econ. 40 : 39-52 View in Article Scopus (0)

Crossref

Google Scholar

185. Lee H

Wildeman C

Wang EA

Matusko N

Jackson JS A heavy burden: the cardiovascular health consequences of having a family member incarcerated. Am J Public Health. 104 : 421-427 View in Article Scopus (25)

PubMed

Crossref

Google Scholar

187. Wakefield S

Wildeman C Children of the prison boom: mass incarceration and the future of American inequality. Oxford University Press , Oxford View in Article Crossref

Google Scholar

189. Wildeman C

Muller C Mass imprisonment and inequality in health and family life. Ann Rev Law Social Sci. 8 : 11-30 View in Article Scopus (0)

Crossref

Google Scholar

190. Wildeman C

Schnittker J

Turney K Despair by association? The mental health of mothers with children by recently incarcerated fathers. Am Sociol Rev. 77 : 216-243 View in Article Scopus (65)

Crossref

Google Scholar

191. Christian J Riding the bus barriers to prison visitation and family management strategies. J Contemporary Criminal Justice. 21 : 31-48 View in Article Scopus (0)

Crossref

Google Scholar

192. Codd H In the shadow of prison: families, imprisonment and criminal justice. Willan , Cullompton, Devon View in Article Google Scholar

194. Mannelli P The burden of caring: drug users and their families. Indian J Med Res. 137 : 636-638 View in Article PubMed

Google Scholar

195. Comfort M Doing time together: love and family in the shadow of the prison. University of Chicago Press , Chicago View in Article Google Scholar

196. Richie BE The social impact of mass incarceration on women. in: Mauer M Chesney-Lind M Invisible punishment: the collateral consequences of mass imprisonment. New Press , New York : 136-149 View in Article Google Scholar

197. Girshick LB Soledad women: Wives of prisoners speak out. Greenwood Publishing Group , Westport, CT View in Article Google Scholar

198. Comfort M. “A twenty hour a day job”: the repercussive effects of frequent low-level criminal justice involvement on family life. Ann Am Acad Pol Soc Sci (in press). View in Article Google Scholar

201. Carpentier C

Royuela L

Noor A

Hedrich D Ten years of monitoring illicit drug use in prison populations in Europe: issues and challenges. Howard J Criminal Justice. 51 : 37-66 View in Article Scopus (0)

Crossref

Google Scholar

203. UN Office on Drugs and Crime

UNAIDS

World Bank HIV in prisons: Sub-Saharan Africa—opportunities for action. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

205. Larney S

Kopinski H

Beckwith CG

et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 58 : 1215-1224 View in Article Scopus (71)

PubMed

Crossref

Google Scholar

206. Treloar C

McCredie L

Lloyd AR Acquiring hepatitis C in prison: the social organisation of injecting risk. Harm Reduct J. 12 : 10 View in Article PubMed

Crossref

Google Scholar

207. Bretana NA

Boelen L

Bull R

et al. Transmission of hepatitis C Virus among prisoners, Australia, 2005–2012. Emerg Infect Dis. 21 : 765-774 View in Article PubMed

Crossref

Google Scholar

208. Bocai A

Iliuta C

Ursan M

Corciova M HIV, HBV and HCV behavioral surveillance survey among injecting drug users in Bucharest, Romania. United Nations Office on Drugs and Crime , Bucharest View in Article Google Scholar

209. Grau LE

White E

Niccolai LM

et al. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St Petersburg, Russian Federation. AIDS Behav. 15 : 45-57 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

210. Hope VD

Hickman M

Ngui SL

et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 18 : 262-270 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

211. Li L

Assanangkornchai S

Duo L

McNeil E

Li J Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China–Myanmar border city: results from a respondent-driven sampling survey in 2012. PLoS One. 9 : e106899 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

212. Butler T

Boonwaat L

Hailstone S

et al. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Aust N Z J Public Health. 31 : 44-50 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

213. Hickman M

Hope V

Brady T

et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat. 14 : 645-652 View in Article Scopus (58)

PubMed

Crossref

Google Scholar

214. Kheirandish P

SeyedAlinaghi S

Jahani M

et al. Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. J Urban Health. 86 : 902-908 View in Article Scopus (26)

PubMed

Crossref

Google Scholar

219. Milloy MJ

Wood E

Small W

et al. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev. 27 : 693-699 View in Article Scopus (45)

PubMed

Crossref

Google Scholar

220. Milloy MJ

Buxton J

Wood E

Li K

Montaner JS

Kerr T Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health. 9 : 156 View in Article Scopus (21)

PubMed

Crossref

Google Scholar

221. Wood E

Li K

Small W

Montaner JS

Schechter MT

Kerr T Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep. 120 : 150-156 View in Article PubMed

Crossref

Google Scholar

222. Martin NK

Vickerman P

Brew I

et al. Is increased HCV case-finding combined with current or 8-12 week interferon-free DAA therapy cost-effective in UK prisons? A prevention benefit analysis. Hepatology. ( ) https://doi.org/10.1002/hep.28497 View in Article Scopus (5)

Crossref

Google Scholar

224. Dolan K

Teutsch S

Scheuer N

et al. Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol. 25 : 143-148 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

226. Buavirat A

Page-Shafer K

van Griensven GJ

et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 326 : 308 View in Article PubMed

Crossref

Google Scholar

227. Hayashi K

Ti L

Csete J

et al. Reports of police beating and associated harms among people who inject drugs in Bangkok, Thailand: a serial cross-sectional study. BMC Public Health. 13 : 733 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

228. Biadglegne F

Rodloff AC

Sack U Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 143 : 887-900 View in Article PubMed

Crossref

Google Scholar

229. Stuckler D

Basu S

McKee M

King L Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci USA. 105 : 13280-13285 View in Article Scopus (76)

PubMed

Crossref

Google Scholar

230. WHO/Europe

UN Office on Drugs and Crime Good governance for prison health in the 21st century. A policy brief on the organization of prison health. World Health Organization Regional Office for Europe , Copenhagen View in Article Google Scholar

231. European Centre for Disease Prevention and Control Thematic report: prisoners—monitoring implementation of the Dublin Declaration on Partnership to fight HIV/AIDS in Europe and central Asia: 2012 progress report. European Centre for Disease Prevention and Control , Stockholm View in Article Google Scholar

233. Russian Federal Penitentiary Service Statistics of the federal pentitentiary system. http://xn--h1akkl.xn--p1ai/statistics/ View in Article Google Scholar

234. UN General Assembly Basic principles for the treatment of prisoners. UN doc. A/RES/45/111. United Nations , New York View in Article Google Scholar

235. UN Office on Drugs and

WHO

UNAIDS

UNDP

International Labour Organization Policy brief: HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

236. European Monitoring Centre on Drugs and Drug Addiction Prisons and drugs in Europe: the problem and responses. European Monitoring Centre on Drugs and Drug Addiction , Lisbon View in Article Google Scholar

237. Kopak AM Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders. Int J Prison Health. 11 : 4-16 View in Article PubMed

Crossref

Google Scholar

238. Mitruka K

Tsertsvadze T

Butsashvili M

et al. Launch of a nationwide hepatitis C elimination program—Georgia, April 2015. MMWR. 64 : 753-757 View in Article PubMed

Crossref

Google Scholar

239. Westergaard RP

Spaulding AC

Flanigan TP HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 26 : 10-16 View in Article Scopus (22)

PubMed

Crossref

Google Scholar

240. Small W

Wood E

Betteridge G

Montaner J

Kerr T The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 21 : 708-714 View in Article Scopus (46)

PubMed

Crossref

Google Scholar

241. Milloy MJ

Kerr T

Buxton J

et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 203 : 1215-1221 View in Article Scopus (76)

PubMed

Crossref

Google Scholar

242. Westergaard RP

Kirk GD

Richesson DR

Galai N

Mehta SH Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 53 : 725-731 View in Article Scopus (35)

PubMed

Crossref

Google Scholar

243. Werb D

Milloy MJ

Kerr T

Zhang R

Montaner J

Wood E Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting. AIDS Behav. 17 : 68-73 View in Article Scopus (7)

PubMed

Crossref

Google Scholar

245. Jurgens R Interventions to address HIV in prison (Evidence for Action series). World Health Organization , Geneva View in Article Google Scholar

247. Todrys KW

Amon JJ

Malembeka G

Clayton M Imprisoned and imperiled: access to HIV and TB prevention and treatment, and denial of human rights, in Zambian prisons. J Int AIDS Soc. 14 : 8 View in Article Scopus (15)

PubMed

Crossref

Google Scholar

248. Shalihu N

Pretorius L

van Dyk A

Vander Stoep A

Hagopian A Namibian prisoners describe barriers to HIV antiretroviral therapy adherence. AIDS Care. 26 : 968-975 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

249. Chakrapani V

Kamei R

Kipgen H

Kh JK Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users. Int J Prison Health. 9 : 82-91 View in Article PubMed

Crossref

Google Scholar

250. Alpert M

Wickersham JA

Vazquez M

Altice FL Alcohol use disorders and antiretroviral therapy among prisoners in Argentina. Int J Prison Health. 9 : 40-50 View in Article PubMed

Crossref

Google Scholar

251. Prellwitz IM

Alves BM

Ikeda ML

et al. HIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern Brazil. PLoS One. 8 : e69033 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

252. Wilson D

Ford N

Ngammee V

Chua A

Kyaw MK HIV prevention, care, and treatment in two prisons in Thailand. PLoS Med. 4 : e204 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

253. WHO Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. World Health Organization , Geneva View in Article Google Scholar

255. Lee D

Lal SS

Komatsu R

Zumla A

Atun R Global fund financing of tuberculosis services delivery in prisons. J Infect Dis. 205 : S274-S283 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

256. Iroh PA

Mayo H

Nijhawan AE The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 105 : e5-16 View in Article Scopus (16)

PubMed

Crossref

Google Scholar

257. Pan American Health Organization Improving access of key populations to comprehensive HIV health services: towards a Caribbean consensus. Pan American Health Organization , Washington, DC View in Article Google Scholar

258. Mathers BM

Degenhardt L

Bucello C

Lemon J

Wiessing L

Hickman M Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 91 : 102-123 View in Article Scopus (100)

PubMed

Crossref

Google Scholar

259. WHO Community management of opioid overdose. World Health Organization , Geneva View in Article Google Scholar

261. Vanichseni S

Martin M

Suntharasamai P

et al. High mortality among non-HIV-infected people who inject drugs in Bangkok, Thailand, 2005–2012. Am J Public Health. 105 : 1136-1141 View in Article PubMed

Crossref

Google Scholar

262. Van Amsterdam J

van den Brink W The misuse of prescription opioids: a threat for Europe?. Current Drug Abuse Rev. 8 : 3-14 View in Article PubMed

Crossref

Google Scholar

263. Polomeni P

Schwan R Management of opioid addiction with buprenorphine: French history and current management. Int J Gen Med. 7 : 143-148 View in Article PubMed

Google Scholar

265. Hammersley R

Cassidy MT

Oliver J Drugs associated with drug-related deaths in Edinburgh and Glasgow, November 1990 to October 1992. Addiction. 90 : 959-965 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

267. Cole C

Jones L

McVeigh J

Kicman A

Syed Q

Bellis M Adulterants in illicit drugs: a review of empirical evidence. Drug Testing Analysis. 3 : 89-96 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

269. Farrell M

Hall W Heroin-assisted treatment: has a controversial treatment come of age?. Br J Psychiatry. 207 : 3-4 View in Article PubMed

Crossref

Google Scholar

272. European Monitoring Centre for Drugs and Drug Abuse Perspectives on drugs: preventing overdose deaths in Europe. European Monitoring Centre for Drugs and Drug Abuse , Lisbon View in Article Google Scholar

273. Carter CI

Graham B Opioid overdose prevention and response in Canada. Canadian Drug Policy Coalition , Vancouver View in Article Google Scholar

275. Kerr T

Stoltz JA

Tyndall M

et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 332 : 220-222 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

276. Kerr T

Tyndall MW

Zhang R

Lai C

Montaner JS

Wood E Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health. 97 : 1228-1230 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

277. Wood E

Tyndall MW

Lai C

Montaner JS

Kerr T Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treatment Prev Policy. 1 : 13 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

279. Degenhardt L

Larance B

Bruno R

Lintzeris N

Ali R

Farrell M Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol. Addiction. 110 : 226-237 View in Article Scopus (10)

PubMed

Crossref

Google Scholar

281. Cassidy TA

DasMahapatra P

Black RA

Wieman MS

Butler SF Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation. Pain Med. 15 : 440-451 View in Article Scopus (26)

PubMed

Crossref

Google Scholar

283. Network for Public Health Law Legal interventions to reduce overdose mortality: naloxone access and overdose Good Samaritan laws. Network for Public Health Law , St Paul, MN View in Article Google Scholar

284. Davis CS

Carr D

Southwell JK

Beletsky L Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration. Am J Public Health. 105 : 1530-1537 View in Article PubMed

Crossref

Google Scholar

285. Hammett TM

Phan S

Gaggin J

et al. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries. BMC Health Serv Res. 14 : 261 View in Article Scopus (15)

PubMed

Crossref

Google Scholar

286. Gallant J Drug addiction: Ontario buys naloxone, an overdose life-saver, and then locks it up. http://www.thestar.com/news/gta/2013/07/29/drug_addiction_ontario_buys_naloxone_an_overdose_lifesaver_then_locks_it_up.html View in Article Google Scholar

287. American Pharmacists Association CVS pharmacy expands naloxone access in 12 more states. http://www.pharmacist.com/cvspharmacy-expands-naloxone-access-12-more-states View in Article Google Scholar

288. Drug Policy Alliance Federal lawmakers introducing naloxone prevention bill to combat heroin and opioid overdose crisis (press statement). Drug Policy Alliance , New York View in Article Google Scholar

289. Human Rights Watch Torture in the name of treatment: Human rights abuses in Vietnam, China, Cambodia and Lao PDR. Human Rights Watch , New York View in Article Google Scholar

290. WHO Western Pacific Regional Office Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles. World Health Organization Western Pacific Regional Office , Manila View in Article Google Scholar

291. International Labour Organization

UNDP

UNAIDS Joint statement: Compulsory drug detention and rehabilitation centres. United Nations , Geneva View in Article Google Scholar

292. Saucier R

Wolfe D Privatizing cruelty—torture, inhumane and degrading treatment in non-governmental drug rehabilitation centers. Center for Human Rights and Humanitarian Law. Torture in health care settings: reflection on the Special Rapporteur on Torture's 2013 report. American University , Washington, DC : 123-132 View in Article Google Scholar

293. UN Office on Drugs and Crime From coercion to cohesion: treating drug dependence through health care, not punishment. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

294. O'Neill KL On liberation crack, christianity, and captivity in postwar Guatemala City. Social Text. 32 : 11-28 View in Article Crossref

Google Scholar

295. Wolfe D Death, drug treatment, and Christ's love. Open Society Foundations , New York View in Article Google Scholar

296. Human Rights Watch ‘Like a death sentence’: abuses against persons with mental disabilities in Ghana. Human Rights Watch , New York View in Article Google Scholar

297. Mendez J Report of the special rapporteur on torture and other cruel, inhuman or degrading treatment or punishment, addendum: mission to Ghana. UN doc. A/HRC/25/60/Add.1. United Nations , Geneva View in Article Google Scholar

298. Sun HM

Li XY

Chow EP

et al. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 5 : e005997 View in Article Scopus (0)

Crossref

Google Scholar

299. Dennis BB

Naji L

Bawor M

et al. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Syst Rev. 3 : 105 View in Article Scopus (11)

PubMed

Crossref

Google Scholar

300. European Monitoring Centre for Drugs and Drug Addiction Guidelines for the treatment of drug dependence: a European perspective. European Monitoring Centre for Drugs and Drug Addiction , Lisbon View in Article Google Scholar

301. Faggiano F

Vigna-Taglianti F

Versino E

Lemma P Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev. 3 ( ) View in Article Google Scholar

302. Fareed A

Casarella J

Amar R

Vayalapalli S

Drexler K Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis. 29 : 1-14 View in Article Scopus (34)

PubMed

Crossref

Google Scholar

303. Fareed A

Casarella J

Roberts M

et al. High dose versus moderate dose methadone maintenance: is there a better outcome?. J Addict Dis. 28 : 399-405 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

304. Lambdin BH

Masao F

Chang O

et al. Methadone treatment for HIV prevention—feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 59 : 735-742 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

305. Donny EC

Brasser SM

Bigelow GE

Stitzer ML

Walsh SL Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction. 100 : 1496-1509 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

306. WHO Regional Office for the Western Pacific Clinical guidelines for withdrawal management and treatment of drug dependence in closed settings. World Health Organization Regional Office for the Western Pacific , Manila View in Article Google Scholar

308. Fischer B

Oviedo-Joekes E

Blanken P

et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health. 84 : 552-562 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

309. Fischer B

Murphy Y

Rudzinski K

MacPherson D Illicit drug use and harms, and related interventions and policy in Canada: a narrative review of select key indicators and developments since 2000. Int J Drug Policy. 27 : 23-35 View in Article PubMed

Summary

Full Text

Full Text PDF

Google Scholar

310. Keller J Judge grants injunction allowing doctors to prescribe heroin to group of Vancouver addicts. http://news.nationalpost.com/news/canada/judge-grants-injunction-allowing-doctors-to-prescribe-heroin-to-group-of-vancouver-addicts View in Article Google Scholar

311. Csete J Costs and benefits of drug-related health services. in: Collins J Ending the drug wars: report of the LSE Expert Group on the Economics of Drug Policy. London School of Economics , London : 70-76 View in Article Google Scholar

313. McCollister KE

French MT The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. Addiction. 98 : 1647-1659 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

314. Xing Y

Sun J

Cao W

et al. Economic evaluation of methadone maintenance treatment in HIV/AIDS control among injecting drug users in Dehong, China. AIDS Care. 24 : 756-762 View in Article Scopus (9)

PubMed

Crossref

Google Scholar

315. Ni MJ

Fu LP

Chen XL

Hu XY

Wheeler K Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005–2010). BMC Public Health. 12 : 572 View in Article Scopus (8)

PubMed

Crossref

Google Scholar

316. Dursteler KM

Berger EM

Strasser J

et al. Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence. Subst Abuse Rehab. 6 : 61-74 View in Article PubMed

Crossref

Google Scholar

318. De Jesus Mari J

Tofoli LF

Noto C

et al. Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies. Drugs. 73 : 1549-1568 View in Article PubMed

Crossref

Google Scholar

320. Andrews C

Abraham A

Grogan CM

et al. Despite resources from the ACA, most states do little to help addiction treatment programs implement health care reform. Health Affairs. 34 : 828-835 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

321. Burns K Women, harm reduction and HIV: key findings from Azerbaijan, Georgia, Kyrgyzstan, Russia and Ukraine. Open Society Foundations , New York View in Article Google Scholar

323. De Bortoli L

Coles J

Dolan M Linking illicit substance misuse during pregnancy and child abuse: what is the quality of the evidence?. Child Family Social Work. 19 : 136-148 View in Article Crossref

Google Scholar

324. UN Office on Drugs and Crime Substance abuse treatment and care for women: case studies and lessons learned. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar

325. Mayes LC

Granger RH

Bornstein MH

Zuckerman B The problem of prenatal cocaine exposure. A rush to judgment. JAMA. 267 : 406-408 View in Article PubMed

Crossref

Google Scholar

326. Hurt H

Betancourt LM

Malmud EK

et al. Children with and without gestational cocaine exposure: a neurocognitive systems analysis. Neurotoxicol Teratol. 31 : 334-341 View in Article PubMed

Crossref

Google Scholar

327. Jones HE

Kaltenbach K

Heil SH

et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 363 : 2320-2331 View in Article Scopus (313)

PubMed

Crossref

Google Scholar

328. Abrahams R

Albizu-Garcia C

Bakker A

et al. Open letter regarding alarmist and inaccurate reporting on prescription opioid use by pregnant women. http://advocatesforpregnantwomen.org/Opioid%20Open%20Letter%20-%20March%202013%20-%20FINAL.pdf View in Article Google Scholar

329. Roberts A

Mathers B

Degenhardt L Women who inject drugs: a review of their risks, experiences and needs. A report prepared on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use. National Drug and Alcohol Research Centre, University of New South Wales , Sydney View in Article Google Scholar

330. International Narcotics Control Board Annual report for 2014. International Narcotics Control Board , Vienna View in Article Google Scholar

331. WHO Ensuring balance in national policies on controlled substances: guidance for availability and accessibility of controlled medicines. World Health Organization , Geneva View in Article Google Scholar

332. Pain & Policy Studies Group Achieving balance in state pain policy: a progress report card (CY 2013). University of Wisconsin Carbone Cancer Center , Madison, WI View in Article Google Scholar

334. Republic of India Narcotic Drugs and Psychotropic Substances Act 1985. Enactment no. 61, 16. http://www.cbn.nic.in/html/ndpsact1985.pdf Date: 1985 View in Article Google Scholar

335. Global Commission on Drug Policy The negative impact of drug control on public health: the global crisis of avoidable pain. Global Commission on Drug Policy , Rio de Janeiro View in Article Google Scholar

336. Bandewar SV Access to controlled medicines for palliative care in India: gains and challenges. Indian J Med Ethics. 12 : 77-82 View in Article PubMed

Google Scholar

337. Human Rights Watch World report 2014 (India chapter). Human Rights Watch , New York View in Article Google Scholar

344. Whiting PF

Wolff RF

Deshpande S

et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 313 : 2456-2473 View in Article PubMed

Crossref

Google Scholar

345. Deshpande A

Mailis-Gagnon A

Zoheiry N

Lakha SF Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials. Can Fam Physician. 61 : e372-e381 View in Article PubMed

Google Scholar

346. Madras B Update of cannabis and its medical use. Review for the 37th session of the WHO Expert Committee on Drug Dependence. World Health Organization , Geneva View in Article Google Scholar

347. WHO

Expert Committee on Drug Dependence Extract from the Report of the 37th Expert Committee on Drug Dependence, convened from 16 to 20 November 2015, at WHO headquarters in. Commission on Narcotic Drugs , Geneva View in Article Google Scholar

348. Hall W

Weier M Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther. 97 : 607-615 View in Article Scopus (26)

PubMed

Crossref

Google Scholar

350. Pacula RL

Powell D

Heaton P

Sevigny EL Assessing the effects of medical marijuana laws on marijuana use: the devil is in the details. J Policy Analysis Mgt. 34 : 7-31 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

351. Bachhuber MA

Saloner B

Cunningham CO

Barry CL Medical cannabis laws and opioid analgesic overdose mortality in the united states, 1999–2010. JAMA Intern Med. 174 : 1668-1673 View in Article Scopus (81)

PubMed

Crossref

Google Scholar

352. University of New South Wales Injecting drug users reference group: the Reference Group to the UN on HIV and Injecting Drug Use. https://ndarc.med.unsw.edu.au/project/injecting-drug-users-reference-group-reference-group-un-hiv-and-injecting-drug-use View in Article Google Scholar

353. Degenhardt L

Larance B

Mathers B

et al.

on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use Benefits and risks of pharmaceutical opioids: essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV. Reference Group Thematic Paper Series. National Drug and Alcohol Research Centre, University of New South Wales , Sydney View in Article Google Scholar

354. Degenhardt L

Mathers B

Guarinieri M

et al.

on behalf of the Reference Group to the United Nations on HIV and Injecting Drug Use The global epidemiology of methamphetamine injection: a review of the evidence on use and associations with HIV and other harm. Reference Group Thematic Paper Series. National Drug and Alcohol Research Centre, University of New South Wales , Sydney View in Article Google Scholar

358. UNDP Request for proposals: national survey on drug use in Nigeria. http://procurement-notices.undp.org/view_file.cfm?doc_id=29568 View in Article Google Scholar

359. Buxton J Drugs and development: the great disconnect. Global Drug Policy Observer (Swansea). http://www.swansea.ac.uk/media/The%20Great%20Disconnect.pdf View in Article Google Scholar

360. UN Office on Drugs and Crime Southeast Asia opium survey 2014 Lao PDR, Myanmar. United Nations Office on Drugs and Crime , Bangkok View in Article Google Scholar

361. Fishstein P Despair or hope: rural livelihoods and opium poppy dynamics in rural Afghanistan. Afghanstan Research and Evaluation Unit , Kabul View in Article Google Scholar

362. Mansfield D Assessing supply-side policy and practice: eradication and alternative development. Global Commission on Drug Policy working paper. http://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Com_David_Mansfield.pdf Date: 2011 View in Article Google Scholar

363. Mejía D

Restrepo P

Rozo SV On the effects of enforcement on illegal markets: evidence from a quasi-experiment in Colombia. Universidad de los Andes , Bogotá View in Article Google Scholar

365. UN Office on Drugs and Crime

Government of Colombia Colombia coca cultivation survey 2013. United Nations Office on Drugs and Crime , Bogotá View in Article Google Scholar

366. Mansfield D

Pain A Alternative livelihoods: substance or slogan? Afghanistan Research and Evaluation Unit , Kabul View in Article Google Scholar

367. Camacho A

Mejía D The health consequences of aerial spraying of illicit crops: the case of Colombia (working paper 408). Center for Global Development , Washington, DC View in Article Google Scholar

368. UN Office on Drugs and Crime

Plurinational State of Bolivia Estado Plurinacional de Bolivia: Monitoreo de cultivos de coca 2014. United Nations Office on Drugs and Crime , La Paz View in Article Google Scholar

369. UN Office on Drugs and Crime

Government of Colombia Colombia coca cultivation survey 2014. United Nations Office on Drugs and Crime , Bogotá View in Article Google Scholar

370. UN Office on Drugs and Crime

National Drug Commission of Peru Peru: Monitoreo de cultivas de coca 2014. United Nations Office on Drugs and Crime , Lima View in Article Google Scholar

371. Mejía D Plan Colombia: an analysis of effectiveness and costs. Brookings Institution , Washington, DC View in Article Google Scholar

372. Solomon KR

Anadón A

Cerdeira AL

Marshall J

Sanin L-H Environmental and human health assessment of the aerial spray program for coca and poppy control in Colombia. Prepared for the Inter-American Drug Abuse Control Commission section of the Organization of American States. Organization of American States , Washington, DC View in Article Google Scholar

373. Transnational Institute The CICAD study on the impacts of glyphosate and the crop figures: the politics of glyphosate. Drug Policy Briefing no. 14. Transnational Institute , Amsterdam View in Article Google Scholar

374. Rincón-Ruiz A

Kallis G Caught in the middle, Colombia's war on drugs and its effects on forest and people. Geoforum. 46 : 60-78 View in Article Scopus (0)

Crossref

Google Scholar

375. Republic of Ecuador Application instituting proceedings submitted to International Court of Justice, General List no. 138. http://www.icj-cij.org/docket/files/138/14474.pdf Date: 2008 View in Article Google Scholar

378. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans: preamble. International Agency for Research on Cancer , Lyon View in Article Google Scholar

379. UN Women A gender perspective on the impact of drug use, the drug trade, and drug control regimes: UN Women policy brief. United Nations Women , New York View in Article Google Scholar

382. German Federal Ministry for Economic Cooperation and Development Rethinking the approach of alternative development: principles and standards of rural development in drug producing areas. Deutsche Gesellschaft für Internationale Zusammenarbeit , Berlin View in Article Google Scholar

384. Domosławski A Drug policy in Portugal: the benefits of decriminalizing drug use. Open Society Foundations Global Drug Policy Program , New York View in Article Google Scholar

385. Hughes CE

Stevens A What can we learn from the Portuguese decriminalization of illicit drugs?. Br J Criminol. 50 : 999-1022 View in Article Scopus (92)

Crossref

Google Scholar

386. Hughes CE

Stevens A A resounding success or a disastrous failure: re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs. Drug Alcohol Rev. 31 : 101-113 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

387. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Statistical bulletin 2011. http://www.emcdda.europa.eu/stats11 View in Article Google Scholar

389. Csete J From the mountaintops: what the world can learn from drug policy change in Switzerland. Open Society Foundations , New York View in Article Google Scholar

391. Rihs-Middel M

Hämmig R

Jacobshagen N Heroin-assisted treatment: work in progress. Swiss Federal Office of Public Health , Bern View in Article Google Scholar

392. Güttinger F

Gschwend P

Schulte B

Rehm J

Uchtenhagen A Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. Eur Addiction Res. 9 : 73-79 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

394. Strang J

Groshkova T

Uchtenhagen A

et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addictiondagger. Br J Psychiatry. 207 : 5-14 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

395. Withnall A Switzerland changes law to decriminalise marijuana possession. http://www.independent.co.uk/news/world/europe/switzerland-changes-law-to-decriminalise-marijuana-possession-8856308.html View in Article Google Scholar

396. Kalina K Developing the system of drug services in the Czech Republic. J Drug Issues. 37 : 181-204 View in Article Crossref

Google Scholar

397. Zábranský T Czech drug laws as an arena of drug policy battle. J Drug Issues. 34 : 661-686 View in Article Crossref

Google Scholar

398. Csete J A balancing act: policymaking on illicit drugs in the Czech Republic. Open Society Foundations , New York View in Article Google Scholar

399. European Monitoring Centre for Drugs and Drug Addiction Alternatives to punishment for drug using offenders. European Monitoring Centre for Drugs and Drug Addiction , Lisbon View in Article Google Scholar

400. Strathdee SA

Patrick DM

Currie SL

et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 11 : F59-F65 View in Article Scopus (444)

PubMed

Crossref

Google Scholar

402. Tyndall MW

Currie S

Spittal P

et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 17 : 887-893 View in Article Scopus (254)

PubMed

Crossref

Google Scholar

403. Urban Health Research Initiative Drug situation in Vancouver. Urban Health Research Initiative , Vancouver View in Article Google Scholar

404. Kerr T

Small W

Buchner C

et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 100 : 1449-1453 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

406. Wood E

Kerr T

Marshall BDL

et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 338 : b1649 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

410. Tran OC

Bruce RD

Masao F

et al. Implementation and operational research: linkage to care among methadone clients living with HIV in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 69 : e43-e48 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

411. Gupta A

Mbwambo J

Mteza I

et al. Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis. 18 : 793-798 View in Article Scopus (0)

PubMed

Crossref

Google Scholar

412. UN Office on Drugs and Crime Drug use and trafficking in Senegal: strengthening monitoring and treatment centres. https://www.unodc.org/westandcentralafrica/en/senegal---drug-monitoring-and-rehabilitation.html View in Article Google Scholar

414. Hoover J

Jürgens R Harm reduction in prison: the Moldova model. Open Society Institute , New York View in Article Google Scholar

415. Doltu S Presentation to the UNAIDS Programme Coordination Board. http://www.unaids.org/sites/default/files/media_asset/20151012_UNAIDS_PCB37_15-21_EN.pdf View in Article Google Scholar

416. Open Society Foundations Stopping overdose: peer-based distribution of naloxone. Open Society Foundations , New York View in Article Google Scholar

417. Coffin PO

Sullivan SD Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ. 16 : 1051-1060 View in Article Scopus (11)

PubMed

Crossref

Google Scholar

418. Bird SM

Parmar MKB

Strang J Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy. 22 : 66-76 View in Article Scopus (0)

Crossref

Google Scholar

419. Watt G

Jaquet S

Ellison S

Christie I

Nicholson J Service evaluation of Scotland's national take-home naloxone programme. Scottish Government Social Research , Edinburgh View in Article Google Scholar

424. UNAIDS Alternative action on compulsory detention: innovative responses in Asia. http://www.unaids.org/en/resources/presscentre/featurestories/2012/october/20121005detentioncenters/ View in Article Google Scholar

426. UN Office on Drugs and Crime Bolivia to re-acceded to UN drug convention while making exception on coca leaf chewing. https://www.unodc.org/unodc/en/frontpage/2013/January/bolivia-to-re-accede-to-un-drug-convention-while-making-exception-on-coca-leaf-chewing.html View in Article Google Scholar

427. Ledebur K

Youngers CA From conflict to collaboration: an innovative approach to reducing coca cultivation in Bolivia. Stability. 2 ( ) View in Article Scopus (3)

Crossref

Google Scholar

428. UN International Covenant on Civil and Political Rights. UNGA res. 2200A (XXI). United Nations , New York View in Article Google Scholar

429. UN Economic and Social Council Siracusa principles on the limitation and derogation provisions in the International Covenant on Civil and Political Rights. UN doc. E/CN.4/1985/4 Annex. United Nations Economic and Social Council , New York View in Article Google Scholar

430. UN Office on Drugs and Crime Making drug control ‘fit for purpose’: building on the UNGASS decade. United Nations Office on Drugs and Crime , Vienna View in Article Google Scholar